The acquisition also encompasses a promising clinical pipeline targeting generalized anxiety disorder and Alzheimer ... as measured by both clinician-rated and patient-reported outcomes.

Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

They can also help improve mood and reduce anxiety. Saffron contains compounds that act as a natural antidepressant and ... However, some top-rated brands include Pure Encapsulations, Life ...

The secondary outcomes are sleep parameters recorded in the actigraphy, Hamilton Rating Scale for Depression score and Self-rating Anxiety Scale score. Daily dose of patients’ antidepressant ... ended ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term use of conventional antidepressants, there is a need for novel rapid acting ...

Marijuana access introduces an alternative treatment to traditional prescription medication that may provide easier access ...

Does this approach make sense? A. Venlafaxine (Effexor) is a short-acting antidepressant, which can make it challenging to discontinue. A three-day “taper” might not be long enough.

It has been nearly two decades since Tom Cruise used his appearance on Today to criticize Brooke Shields for taking antidepressants while battling postpartum depression. The unhinged 2005 rant ...

Tom Cruise privately expressed remorse over his “ridiculous rant” about Brooke Shields’ use of antidepressants, the actress revealed in her new memoir. The Golden Globe nominee wrote in ...